Alumina ceramic particles, in comparison with titanium particles, hardly affect the expression of RANK-, TNF-α-, and OPG-mRNA in the THP-1 human monocytic cell line

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 3, 2009, Pages 707-716

  Bylski, David ^a   Wedemeyer, Christian ^a   Xu, Jie ^b   Sterner, Thomas ^a   Löer, Franz ^a   Von Knoch, Marius ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Aseptic osteolysis; Ceramic wear particles; Monocytes; RANK RANKL OPG system; TNF

Indexed keywords

ALUMINA CERAMIC; ASEPTIC LOOSENING; ASEPTIC OSTEOLYSIS; BIOINERT; CERAMIC PARTICLE; CERAMIC WEAR PARTICLES; CONCENTRATION OF; KEY REGULATORS; MACROPHAGE-LIKE CELLS; MONOCYTES; MONOCYTIC CELLS; MRNA EXPRESSION; OSTEOLYSIS; QUANTITATIVE RT-PCR; RANK/RANKL/OPG-SYSTEM; SMALL PARTICLES; TIME POINTS; TITANIUM PARTICLES; TOTAL JOINT REPLACEMENT; UP-REGULATION; UPREGULATIONS;

ALUMINA; BODY FLUIDS; CELL CULTURE; JOINT PROSTHESES; NUCLEIC ACIDS; RNA; TITANIUM;

CERAMIC MATERIALS;

ALUMINUM OXIDE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TITANIUM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOCOMPATIBILITY; CELL LINE; CELL SURVIVAL; CERAMICS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; OSTEOLYSIS; PARTICLE SIZE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ALUMINUM OXIDE; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; MONOCYTES; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RNA, MESSENGER; TITANIUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66249117339     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31956     Document Type: Article

References (36)

1. Skoglund B, Aspenberg P. PMMA particles and pressure-A study of the osteolytic properties of two agents proposed to cause prosthetic loosening. J Orthop Res 2003;21:196-201.
2. Aspenberg P. Wear and osteolysis in total joint replacements. Acta Orthop Scand 1998;69:435-436.
3. Mariani BD, Martin DS, Levine MJ, Booth RE Jr, Tuan RS. The Coventry Award. Polymerase chain reaction detection of bacterial infection in total knee arthroplasty. Clin Orthop Relat Res 1996;331:11-22.
4. Silva MJ, Sandell LJ What's new in orthopaedic research. J Bone Joint Surg Am 2002;84A: 1490-1496.
5. Hirashima Y, Ishiguro N, Kondo S, Iwata H. Osteoclast induction from bone marrow cells is due to pro-inflammatory mediators from macrophages exposed to polyethylene particles: A possible mechanism of osteolysis in failed THA. J Biomed Mater Res 2001;56:177-183.
6. Willert HG, Bertram H, Buchhorn GH. Osteolysis in alloar- throplasty of the hip. The role of ultra-high molecular weight polyethylene wear particles. Clin Orthop 1990;258:95-107.
7. Hirayama T, Fujikawa Y, Itonaga I, Torisu T. Effect of particle size on macrophage-osteoclast differentiation in vitro. J Orthop Sci 2001;6:53-58.
8. Sabokbar A, Pandey R, Diaz J, Quinn JM, Murray DW, Atha- nasou NA. Hydroxyapatite particles are capable of inducing osteoclast formation. J Mater Sci Mater Med 2001;12:659- 664.
9. Pandey R, Quinn J, Joyner C, Murray DW, Triffitt JT, Athana- sou NA. Arthroplasty implant biomaterial particle associated macrophages differentiate into lacunar bone resorbing cells. Ann Rheum Dis 1996;55:388-395.
10. Quinn J, Joyner C, Triffitt JT, Athanasou NA. Polymethylme- thacrylate-induced inflammatory macrophages resorb bone. J Bone Joint Surg Br 1992;74:652.
11. Crotti TN, Smith MD, Findlay DM, Zreiqat H, Ahem MJ, Weedon H, Hatzinikolous G, Capone M, Holding C, Haynes DR. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: Expression of receptor activator NFkappaB. RANK ligand and osteoprotegerin. Bioma- terials 2004;25:565-573.
12. Mandelin J, Li TF, Liljestrom M, Kroon ME, Hanemaaijer R, Santavirta S, Konttinen YT. Imbalance of RANKL/RANK/ OPG system in interface tissue in loosening of total hip replacement. J Bone Joint Surg Br 2003;85:1196-1201.
13. Haynes DR, Crotti TN, Potter AE, Loric M, Atkins GJ, Howie DW, Findlay DM. The osteoclastogenic molecules RANKL and RANK are associated with periprostheticosteolysis. J Bone Joint Surg Br 2001;83:902-911.
14. Baumann B, Rader CP, Seufert J, Noth U, Rolf O, Eulert J, Jakob F. Effects of polyethylene and TiAlV wear particles on expression of RANK. RANKL and OPG mRNA. Acta Orthop Scand 2004;75:295-302.
15. Warashina H, Sakano S, Kitamura S, Yamauchi KI, Yamagu- chi J, Ishiguro N, Hasegawa Y. Biological reaction to alumina, zirconia, titanium and polyethylene particles implanted onto murine calvaria. Biomaterials 2003;24:3655-3661.
16. Yagil-Kelmer E, Kazmier P, Rahaman MN, Bal BS, Tessman RK, Estes DM. Comparison of the response of primary human blood monocytes and the U937 human monocytic cell line to two different sizes of alumina ceramic particles. J Orthop Res 2004;22:832-838.
17. Lee SK, Kalinowski J, Jastrzebski S, Lorenzo JA. l,25(OH)2 vitamin D3-stimulated osteoclast formation in spleen-osteo- blast cocultures is mediated in part by enhanced IL-1 alpha and receptor activator of NF-kappa B ligand production in osteoblasts. J Immunol 2002;169:2374-2380.
18. Kondo T, Kitazawa R, Maeda S, Kitazawa S. l-alpha,25 dihy- droxyvitamin D3 rapidly regulates the mouse osteoprotegerin gene through dual pathways. J Bone Miner Res 2004;19:1411- 1419.
19. Baumann B, Seufert J, Jakob F, Noth U, Rolf O, Eulert J, Rader CP. Activation of NF-kappaB signalling and TNF- alpha-expression in THP-1 macrophages by TiAlV- and polyethylene-wear particles. J Orthop Res 2005;23:1241-1248.
20. Lee SK, Lorenzo JA. Regulation of receptor activator of nuclear factor-kappa B ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase, a pathway in murine bone marrow cultures. Bone 2002;31:252-259.
21. Uchiyama S, Yamaguchi M. Inhibitory effect of beta-cryptox- anthin on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 2004;67:1297-1305.
22. Hatton A, Nevelos JE, Matthews JB, Fisher J, Ingham E. Effects of clinically relevant alumina ceramic wear particles on TNF-αlpha production by human peripheral blood mononuclear phagocytes. Biomaterials 2003;24:1193-1204.
23. Akisue T, Kurosaka M, Matsui N, Yamaguchi M, Hasuda K, Bauer TW, Yoshiya SI. Paratibial cyst associated with wear debris after total knee arthroplasty. J Arthroplasty 2001;16: 389-393.
24. Sundfeldt M, Carlsson LV, Johansson CB, Thomsen P, Gret- zer C. Aseptic loosening, not only a question of wear: A review of different theories. Acta Orthop 2006;77:177- 197.
25. Yoon TR, Rowe SM, Jung ST, Seon KJ, Maloney WJ. Osteolysis in association with a total hip arthroplasty with ceramic bearing surfaces. J Bone Joint Surg Am 1998;80:1459- 1468.
26. Lerouge S, Huk O, Yahia LH, Sedel L. Characterization of in vivo wear debris from ceramic-ceramic total hip arthroplasties. J Biomed Mater Res 1996;32:627-633.
27. von Knoch F, Heckelei A, Wedemeyer C, Saxler G, Hilken G, Brankamp J, Sterner T, Landgraeber S, Henschke F, Loer F, von Knoch M. Suppression of polyethylene particle-induced osteolysis by exogenous osteoprotegerin. J Biomed Mater Res A 2005;75:288-294.
28. Boutin P. Total arthroplasty of the hip by fritted aluminum prosthesis. Experimental study and 1st clinical applications. Rev Chir Orthop Reparatrice Appar Mot 1972;58:229-246.
29. Mahoney OM, Dimon JH III. Unsatisfactory results with a ceramic total hip prosthesis. J Bone Joint Surg Am 1990;72: 663-671.
30. Wirganowicz PZ, Thomas BJ. Massive osteolysis after ceramic on ceramic total hip arthroplasty. A case report. Clin Orthop Relat Res 1997;338:100-104.
31. Nizard RS, Sedel L, Christel P, Meunier A, Soudry M, Wit- voet J. Ten-year survivorship of cemented ceramic-ceramic total hip prosthesis. Clin Orthop Relat Res 1992;282:53- 63.
32. Hamadouche M, Boutin P, Daussange J, Bolander ME, Sedel L. Alumina-on-alumina total hip arthroplasty: A minimum 18.5-year follow-up study. J Bone Joint Surg Am 2002;84A: 69-77.
33. Yoo JJ, Kim YM, Yoon KS, Koo KH, Song WS, Kim HJ. Alumina-on-alumina total hip arthroplasty. A five-year minimum follow-up study. J Bone Joint Surg Am 2005;87:530-535.
34. Wedemeyer C, Neuerburg C, Pfeiffer A, Heckelei A, Bylski D, von Knoch F, Schinke T, Hilken G, Gosheger G, von Knoch M, Loer F, Saxler G. Polyethylene particle induced bone resorption in alpha-caleitonin gene related peptide deficient mice. J Bone Miner Res 2007;22:1011-1019.
35. von Knoch M, Sprecher C, Barden B, Saxler G, Loer F, Wimmer M. Size and shape of commercially available polyethylene particles for in-vitro and in-vivo-experiments. Z Orthop Ihre Grenzgeb 2004;142:366-370.
36. Fang HW, Ho YC, Yang CB, Liu HL, Ho FY, Lu YC, Ma HM, Huang CH. Preparation of UHMWPE particles and establishment of inverted macrophage cell model to investigate wear particles induced bioactivites. J Biochem Biophys Methods 2006;68:175-187.